Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
J., Cherng, W
Disclosure of interest: Sheng-Feng Sung, Cheng-Yang Hsieh, Hsin-Yi Yang, Ching-Fang Tsai, Chen-Wen Fang: nothing to disclose E-Posters - RISK FACTORS - PRIMARY AND SECONDAR PREVENTION 05.00 - RISK FACTORS AND PREVENTION (PRIMARY AND SECONDARY) - 05.02 - SECONDARY PREVENTION P2472 - ESOC25-417 CHANGES IN PLATELET REACTIVITY AFTER DOSE REDUCTION IN PATIENTS WITH ENHANCED RESPONSE TO CLOPIDOGREL: A PAIRED ANALYSIS Jin Soo Lee 1 , Hyeon Min Lee 1 , Bok Seon Yoon 1 , Seong-Joon Lee 1 1 Department of Neurology, Ajou University School of Medicine, Ajou University Medical Center, Suwon, South Korea Background and Aims: While clopidogrel resistance is a well-known concern in cardiovascular and cerebrovascular disease prevention, some patients exhibit enhanced response to standard dosing, potentially increasing bleeding risk
Vitamin B12 is a commonly deficient vitamin in adults
372 In vitro, GLP-1 disrupts the ability of osteoblasts to survive and differentiate by triggering the activation of c-Fos, which is a proto-oncogene
The temperature is cold enough to effectively halt most degradation reactions while being accessible enough for regular use
US$ 25.98
:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)
.jpg)
US$ 27.84
US$ 27.46
